Dana-Farber/Boston Children's Cancer and Blood Disorders Center

healthcare 📍 Boston, United States
2
Erythromelalgia Publications
6
Erythromelalgia Researchers

Associated Institutions

Boston Children's Hospital
parent
Dana-Farber Cancer Institute
parent

Publications

Gene variants associated with pediatric-onset erythromelalgia: Mendelian and rare-variant association analyses.

Yonas MC, Ocay DD, Genetti CA, Lobo K, Fernandes M , et al.
Pain reports

Erythromelalgia is a descriptive term for burning pain and erythema in distal extremities, often worsened by heat and improved by cold. Inherited erythromelalgia has been primarily linked to gain-of-function variants in , encoding voltage-gated sodium channel NaV1.7. However, approximately 65% to 85% of patients with erythromelalgia do not have pathogenic variants. The objective of this study was to uncover and assess gene variants potentially associated with pediatric-onset erythromelalgia. With IRB approval and informed consent, probands and families with erythromelalgia underwent next-generation sequencing. A list of genes of interest was produced based on Mendelian inheritance models. Selected gene candidates were assessed using the Sequence Kernel Association Test-Optimal (SKAT-O). Sixty-two probands with erythromelalgia and their relatives were included in Mendelian analysis, which identified variants in PR domain zinc finger protein 12 () and dihydropyrimidinase-like protein 2 (). In a targeted 12-gene rare-variant set analysis using SKAT-O, zinc finger homeobox protein 2 () showed evidence of association ( = 6.9 × 10), surpassing Bonferroni correction for 12 tests (α = 4.17 × 10), whereas showed only a nominal association signal ( = 0.03) that did not survive multiple-testing correction. Genes associated with both increased and decreased pain sensitivity are of considerable interest for elucidating pain mechanisms and analgesic development. As rare variants in and were identified in a pediatric erythromelalgia cohort and a gene-based rare-variant association signal for was identified, replication and functional validation are needed.

Clinical Characterization of Pediatric Erythromelalgia: A Single-Center Case Series.

Sun J, Ocay DD, Halpin M, Lobo K, Frohman DFT , et al.
Children (Basel, Switzerland)

Erythromelalgia is a descriptive term for severe burning pain and erythema in the distal extremities relieved by cold and exacerbated by heat. Pediatric case series to date are relatively small. We extracted and analyzed medical record data for 42 pediatric patients to describe clinical characteristics, associated conditions, and responses to treatments. Informed consent was obtained according to an IRB-approved protocol that included gene discovery. Three patients had confirmed Nav1.7 sodium channelopathies, with six additional patients under investigation with novel gene candidates. There was a female predominance (2.5:1), and the median onset age was 12 years (IQR = 3-14). Patients saw a median of three specialists (IQR = 2-3) for a diagnosis. The majority (90%) reported bilateral symptoms. Cooling methods usually provided partial relief, while heat and exercise exacerbated pain. No medication appeared to be consistently effective; commonly prescribed medications included sodium channel blockers ( = 37), topical analgesics ( = 26), gabapentin ( = 22), and aspirin ( = 15). Based on the currently published literature, we believe this cohort is the largest pediatric study of erythromelalgia to date. Many findings are consistent with those of previously published case series. Work is in progress to establish a prospective cohort and multi-center registry.